//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
8,083.80-170.0
Stock Analysis, IPO, Mutual Funds, Bonds & More

Sun Pharmaceutical Industries Ltd.

ET 500

Rank 2019
62
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    15:59 | 03-04-2020
  • BSE
    12:00 | 03-04-2020
375.95

Today's Change

32.40 (9.43%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

28,550,650

Open

343.95

Prev. Close

343.55

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)1.00
  • EPS-TTM (Rs.)17.12
  • BV/share (₹)186.40
  • 52Wk L/H317.85/ 640.75
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News

Sun Pharmaceutical Industries Ltd Stock Price F & O Quotes

Buy Sun Pharma, target price Rs 440: Jefferies| Recos
Buy
Hold Sun Pharma, target price Rs 430: HSBC| Recos
Hold
Buy SPARC, price target Rs 190: Kunal Bothra| Recos
Buy
Buy Sun Pharma, target Rs 450: CK Narayan| Recos
Buy
Buy Sun Pharma, target price Rs 434: Jay Thakkar| Recos
Buy
CLSA retains buy on Sun Pharma, target price Rs 540| Recos
Buy
Morgan Stanley overweight on Sun Pharma, target price Rs 505| Recos
Overweight
Sell Sun Pharma, target Rs 395: Shubham Aggarwal| Recos
Sell
HSBC maintains hold on Sun Pharma, target price Rs 400| Recos
Hold
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Trending stocks: Sun Pharma shares slip 4%| News
Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares| Announcement
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Sun Pharmaceutical Industries Ltd.Closure of Trading Window| Announcement
Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares| Announcement
Sun Pharmaceutical Industries Ltd.Board approves Buy-back of equity shares| Announcement
Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Meeting Updates| Announcement
Sun Pharmaceutical Industries Ltd.Outcome Of Board Meeting Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations A...| Announcement
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Sun Pharmaceutical Industries Ltd.Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Tuesday, March 17, 2020 To Consider Int...| Announcement
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Sun Pharmaceutical Industries Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Sun Pharmaceutical Industries Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement

Sun Pharmaceutical Industries Ltd. Share Price Updates

Sun Pharmaceutical Industries Ltd. share price up by 9.43% from its previous close of Rs 343.55. Sun Pharmaceutical Industries Ltd. stock last traded price is 375.95
Sun Pharmaceutical Industries Ltd. Share Price
Value
Today/Current/Last
375.95
Previous Day
343.55
What's your view on Sun Pharmaceutical Industries for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.
Quarterly Results

Figures in Rs. Cr
Dec 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
8,038.65
1.13
4.99
0.00
8154.85
Other Operating Income
116.20
-33.28
39.20
0.00
136.45
Operating Profit
1,841.40
2.89
-14.47
-27.67
2683.77
Other Income
119.88
-40.31
-37.91
-0.05
119.88
EBITDA
1,961.28
-1.47
-16.40
-27.67
2683.77
Interest
62.96
-24.99
-56.52
-0.10
111.00
Depreciation
546.99
15.57
16.12
0.00
546.99
Tax
327.62
23.15
20.93
-9.24
767.02
Net Profit
1,019.38
-4.20
-17.91
-835.00
1019.38
EPS (₹)
3.81
-14.00
-26.45
-94.30
31.95

Sun Pharmaceutical Industries Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
375.95
9.43
11.15
-6.22
-14.55
-18.83
-45.27
-67.85
655.85
13.26
19.66
-1.15
-13.95
-16.81
-54.72
-68.59
382.40
-2.52
-2.51
-25.06
-13.78
-51.39
-42.96
-42.26
449.20
8.57
10.19
3.41
-3.76
-15.58
-23.90
-38.94
274.60
4.07
8.67
3.19
7.69
-20.50
-38.68
-27.89
3146.80
1.67
7.90
-0.76
9.31
14.25
15.77
-14.44
2267.05
-0.13
-3.32
-13.27
8.49
29.43
3.05
0.00
2077.00
6.02
11.66
-5.42
10.12
12.78
40.40
67.08
1901.05
1.28
2.07
-15.13
3.41
10.59
202.64
102.53
1385.55
-0.87
11.28
-4.05
21.49
44.81
117.10
115.78
290.95
4.51
4.77
-6.16
0.95
-4.84
56.65
266.07
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Sun Pharmaceutical Industries Ltd Risk Return Comparison

with peersNew

Sun Pharmaceutical Industries Ltd
Financial Comparison

with peers
Management Efficiency
Sun Pharmaceutical Industries Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
6.43
8.97
-99.01
47.57
Return on Assets (%)
4.69
5.58
-27.48
26.25
Return on capital Employed (%)
6.45
5.71
-130.86
23.02
Fixed Assets Turnover (x)
0.55
-1.83
-193.68
2.83
Profitability and Growth
Gross Profit Margin (%)
15.66
-8.24
-980.00
34.42
Operating Profit Margin(%)
21.70
0.75
-896.19
37.94
Net Profit margin (%)
9.17
1.93
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
2.29
1.62
0.08
9.50
Current Ratio (x)
3.33
2.36
0.21
9.50
Cash ratio (x)
0.72
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.04
0.29
0.00
2.65
Coverage Ratios
Cash flows to long term debt (x)
1.60
3.92
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Sun Pharmaceutical Industries Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
Promoters1,309,055,38154.56
ForeignInstitutions333,282,37913.89
CentralGovt6,430NaN
Others118,536,2194.94
NBanksMutualFunds254,370,46610.60
GeneralPublic181,008,4637.54
FinancialInstitutions203,075,6328.46

MF Ownership Of Sun Pharmaceutical Industries Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
ICICI Pru Value Discovery Direct-G
Portfolio as on 29-02-2020
Equity: Value Oriented
29000670
0.31%
8.04%
1081.43
SBI ETF Nifty 50-D
Portfolio as on 29-02-2020
Equity: Large Cap
15031518
3.98%
0.87%
560.53
ICICI Pru Equity & Debt Direct-G
Portfolio as on 29-02-2020
Hybrid: Aggressive Hybrid
12681235
6.73%
2.29%
472.88
Kotak Equity Arbitrage Direct-G
Portfolio as on 29-02-2020
Hybrid: Arbitrage
10561250
27.28%
2.23%
393.83
Equity: ELSS
3200000
0.00%
1.89%
119.33

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 90191.00 Crore) operating in Pharmaceuticals sector.

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9783.29 Crore to Sales Value (94.95 % of Total Sales) and Other Operating Revenue which contributed Rs 519.92 Crore to Sales Value (5.04 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 8038.65 Crore, up 1.13 % from last quarter Sales of Rs 7949.19 Crore and up 4.99 % from last year same quarter Sales of Rs 7656.71 Crore Company has reported net profit after tax of Rs 1023.71 Crore in latest quarter.

The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Company has S R B C & Co. LLP as its auditors As on 31-12-2019, the company has a total of 2,399,334,970 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors